Decreased serum interleukin-17 and increased transforming growth factor-β levels in subjects with metabolic syndrome (Chennai Urban Rural Epidemiology Study-95)

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 586-590

  Surendar, Jayagopi ^a   Aravindhan, Vivekanandhan ^a   Rao, Maradana Muralidhara ^a   Ganesan, Anbazhagan ^a   Mohan, Viswanathan ^a,b  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Dr Mohan's Diabetes Specialities Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; INDIA; INTERLEUKIN-17; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RURAL POPULATION; TRANSFORMING GROWTH FACTOR BETA; TRIGLYCERIDES;

EID: 79952988264     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.003     Document Type: Article

References (26)

1. Grundy S.M. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
2. Enas E.A. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease J Cardiometab Syndr 2 2007 267 275
3. Esposito K., and Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 14 2004 228 232 (Pubitemid 39611863)
4. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 2004 4 7 (Pubitemid 38032801)
5. Natali A. Metabolic syndrome: at the crossroads of cardiorenal risk J Nephrol 22 2009 29 38
6. Moon Y.S., Kim D.H., and Song D.K. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents Metabolism 53 2004 863 867
7. Kowalska I. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome Metabolism 57 2008 1539 1544
8. Choi K.M. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome Diabetes Res Clin Pract 75 2007 235 240 (Pubitemid 44894605)
9. Sumarac-Dumanovic M. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women Int J Obes (Lond) 33 2009 151 156
10. Suthanthiran M. Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans Kidney Int 76 2009 72 80
11. Deepa M. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I) J Assoc Physicians India 51 2003 863 870 (Pubitemid 41279865)
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
13. Santos S.H. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism Diabetes 57 2008 340 347
14. Romano M. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women J Clin Endocrinol Metab 88 2003 5321 5326 (Pubitemid 37452734)
15. Pfeiffer A. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM Diabetes Care 19 1996 1113 1117 (Pubitemid 26334260)
16. Derhaschnig U. Increased levels of transforming growth factor-beta1 in essential hypertension Am J Hypertens 15 2002 207 211 (Pubitemid 34226183)
17. Sciarretta S. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome Am J Hypertens 20 2007 784 791 (Pubitemid 46951019)
18. Rizvi A.A. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts Am J Med Sci 338 2009 310 318
19. Tesmer L.A. Th17 cells in human disease Immunol Rev 223 2008 87 113 (Pubitemid 351986173)
20. Mensah-Brown E.P. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin Eur J Immunol 36 2006 216 223 (Pubitemid 43116408)
21. Boehm B.O. Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus Mol Immunol 46 2009 2576 2584
22. Nikoopour E. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes J Immunol 184 2010 4779 4788
23. Miossec P., Korn T., and Kuchroo V.K. Interleukin-17 and type 17 helper T cells N Engl J Med 361 2009 888 898
24. Madhur M.S. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction Hypertension 55 2010 500 507
25. Arababadi M.K. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Diabetes Res Clin Pract 87 2010 33 37
26. Deepa R. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES) Metabolism 55 2006 1232 1238 (Pubitemid 44215943)